Adenomyosis is the presence of endometrial glands and mesenchyme in the myometrium, accompanied by compensatory hypertrophy and hyperplasia of the surrounding myometrial cells. The etiology of this disease is still unclear. Most scholars believe that it is related to genetics, injuries such as curettage and cesarean delivery, hyperestrogenemia, and viral infections. The main symptoms are increased menstrual flow and prolonged periods (40-50%), as well as progressive dysmenorrhea that gradually increases. Gynecological examination may reveal a uniformly enlarged or nodular bulge of the uterus. GnRHa may relieve pain and reduce the size of the uterus, but recurs when the drug is discontinued. The general surgical treatment is total hysterectomy, and focal resection is feasible for young patients with fertility requirements, but recurrence is easy after surgery. Interventional therapy is an effective treatment for adenomyosis, suitable for patients of any age and has no effect on fertility. By embolizing the uterine artery, the lesion can be reduced in size, the dysmenorrhea disappears or is significantly shortened and reduced, and the menstrual period and volume return to normal. Interventional surgery has the advantages of quick effect, less repetition, small wound (about 0.5cm in the groin) and quick recovery.